Skip to main navigation Skip to search Skip to main content

An efficient method for the synthesis of peptide aldehyde libraries employed in the discovery of reversible SARS coronavirus main protease (SARS-Cov Mpro) inhibitors

Samer I. Al-Gharabli, Syed T. Ali Shah, Steffen Weik, Marco F. Schmidt, Jeroen R. Mesters, Daniel Kuhn, Gerhard Klebe, Rolf Hilgenfeld, Jörg Rademann*

*Corresponding author for this work

Abstract

A method for the parallel solid-phase synthesis of peptide aldehydes has been developed. Protected amino acid aldehydes obtained by the racemization-free oxidation of amino alcohols with Dess-Martin periodinane were immobilized on threonyl resins as oxazolidines. Following Boc protection of the ring nitrogen to yield the N-protected oxazolidine linker, peptide synthesis was performed efficiently on this resin. A peptide aldehyde library was designed for targeting the SARS coronavirus main protease, SARS-CoV Mpro(also known as 3CLpro), on the basis of three different reported binding modes and supported by virtual screening. A set of 25 peptide aldehydes was prepared by this method and investigated in inhibition assays against SARS-CoV M pro. Several potent inhibitors were found with IC50 values in the low micromolar range. An IC50 of 7.5 μM was found for AcNSTSQ-H and AcESTLQ-H. Interestingly, the most potent inhibitors seem to bind to SARS-CoV Mpro in a noncanonical binding mode.

Original languageEnglish
JournalChemBioChem
Volume7
Issue number7
Pages (from-to)1048-1055
Number of pages8
ISSN1439-4227
DOIs
Publication statusPublished - 01.07.2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Coronavirus related work

  • Research on SARS-CoV-2 / COVID-19

Fingerprint

Dive into the research topics of 'An efficient method for the synthesis of peptide aldehyde libraries employed in the discovery of reversible SARS coronavirus main protease (SARS-Cov Mpro) inhibitors'. Together they form a unique fingerprint.

Cite this